These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12931456)

  • 1. [Pregnancy and inborn errors of metabolism].
    Radomyska B
    Ginekol Pol; 2003 Jun; 74(6):479-85. PubMed ID: 12931456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive effects of maternal metabolic disorders: implications for pediatrics and obstetrics.
    Levy HL
    Turk J Pediatr; 1996; 38(3):335-44. PubMed ID: 8827903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inborn errors of metabolism and pregnancy.
    Walter JH
    J Inherit Metab Dis; 2000 May; 23(3):229-36. PubMed ID: 10863939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and inherited metabolic disorders: maternal and fetal complications.
    Preece MA; Green A
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):444-55. PubMed ID: 12227850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease.
    Yang Z; Yamada J; Zhao Y; Strauss AW; Ibdah JA
    JAMA; 2002 Nov; 288(17):2163-6. PubMed ID: 12413376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between fatty acid oxidation disorders and haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome?
    Holub M; Bodamer OA; Item C; Mühl A; Pollak A; Stöckler-Ipsiroglu S
    Acta Paediatr; 2005 Jan; 94(1):48-52. PubMed ID: 15858960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procreation in families with inborn error of metabolism--new challenges for medical care.
    Taybert J
    Dev Period Med; 2015; 19(4):519-22. PubMed ID: 26982765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inherited metabolic diseases and pregnancy: consequences for mother and child].
    van Spronsen FJ; Molendijk H; Erwich JJ; Smit GP
    Ned Tijdschr Geneeskd; 2003 Feb; 147(6):235-40. PubMed ID: 12621977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy.
    Browning MF; Levy HL; Wilkins-Haug LE; Larson C; Shih VE
    Obstet Gynecol; 2006 Jan; 107(1):115-20. PubMed ID: 16394048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management.
    Shekhawat PS; Matern D; Strauss AW
    Pediatr Res; 2005 May; 57(5 Pt 2):78R-86R. PubMed ID: 15817498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency.
    Wilcken B; Leung KC; Hammond J; Kamath R; Leonard JV
    Lancet; 1993 Feb; 341(8842):407-8. PubMed ID: 8094173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver disease in pregnancy and fetal fatty acid oxidation defects.
    Ibdah JA; Yang Z; Bennett MJ
    Mol Genet Metab; 2000; 71(1-2):182-9. PubMed ID: 11001809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal heterozygosity for a mitochondrial trifunctional protein mutation as a cause for liver disease in pregnancy.
    Blish KR; Ibdah JA
    Med Hypotheses; 2005; 64(1):96-100. PubMed ID: 15533621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
    Ibdah JA; Bennett MJ; Rinaldo P; Zhao Y; Gibson B; Sims HF; Strauss AW
    N Engl J Med; 1999 Jun; 340(22):1723-31. PubMed ID: 10352164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal acute fatty liver of pregnancy and the associated risk for long-chain 3-hydroxyacyl-coenzyme a dehydrogenase (LCHAD) deficiency in infants.
    Bellig LL
    Adv Neonatal Care; 2004 Feb; 4(1):26-32. PubMed ID: 14988877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long chain 3-hydroxyacyl-coA dehydrogenase deficiency, association with HELLP and magnetic resonance spectroscopy findings].
    Deltetto N; Maxit C; Marchione D; Szlago M; Schenone A; Besada CH; Vaccarezza M; Agosta G
    Arch Argent Pediatr; 2012 Aug; 110(4):e63-6. PubMed ID: 22859334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal-fetal outcomes of pregnancies in women treated at an inborn errors of metabolism unit.
    Piñar-Gutiérrez A; Dios Fuentes E; Benítez-Ávila R; de Ana-Lobato L; Bueno-Delgado MDA; Soto-Moreno A; Venegas-Moreno E
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Feb; 70(2):98-106. PubMed ID: 36870805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HELLP syndrome: understanding and management of a pregnancy-specific disease.
    Aloizos S; Seretis C; Liakos N; Aravosita P; Mystakelli C; Kanna E; Gourgiotis S
    J Obstet Gynaecol; 2013 May; 33(4):331-7. PubMed ID: 23654309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HELLP syndrome.
    Buist NR; Winter SC
    JAMA; 1999 Feb; 281(8):704-5. PubMed ID: 10052438
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pregnancy in metabolic diseases with hepatic expression: what risks for the mother and the child?].
    Moreau C; Joueidi Y; Peoc'h K; Bardou-Jacquet E; Le Lous M; Bendavid C; Lavoué V; Damaj L; Dessein AF
    Ann Biol Clin (Paris); 2019 Dec; 77(6):605-618. PubMed ID: 31859638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.